Yongin, South Korea

Hyuk Koo Lee

This inventor holds 5 USPTO granted patents. Top assignee: Cj Corporation. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyuk Koo Lee. Retrieved from https://idiyas.com/inventor/hyuk-koo-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 17.2

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Yongin-si, KR (2004 - 2005)
  • Yongin, KR (2006)

Company Filing History:


Years Active: 2004-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Hyuk Koo Lee

Introduction

Hyuk Koo Lee is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 5 patents to his name, Lee continues to push the boundaries of innovation in his industry.

Latest Patents

Among his latest patents, Lee has developed a crystalline organic acid salt of amlodipine. This innovative compound boasts improved physiochemical properties, along with a preparation method and a pharmaceutical composition that incorporates it. Additionally, he has disclosed a novel organic acid salt of amlodipine, detailing its preparation method and a pharmaceutical composition that utilizes it as a therapeutically active ingredient.

Career Highlights

Hyuk Koo Lee is currently associated with CJ Corporation, where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Lee has collaborated with notable colleagues, including Dong Kwon Lim and Seong Hwan Cho, to further enhance the impact of his research and innovations.

Conclusion

Hyuk Koo Lee's contributions to the pharmaceutical industry exemplify the spirit of innovation and dedication to improving healthcare solutions. His ongoing work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…